Research Paper Volume 15, Issue 22 pp 12927—12951
A novel telomere-related genes model for predicting prognosis and treatment responsiveness in diffuse large B-cell lymphoma
Figure 4. Expression evaluation of candidate TRGs in the model. (A–G) The expression level of 7 TRGs in two DLBCL cell lines (HBL-1 and OCI-LY10), two DLBCL-invaded lymph node samples (DLBCL 1 and DLBCL 2) and seven normal lymph node samples (control 1–7), respectively. (H, I) The expression of (H) TCEAL7, (I) EPHA4, and (J) ELOVL4 in DLBCL group and control group.